MicroRNA-1297 contributes to the progression of human cervical carcinoma through PTEN

Zhihua Chen1, Mengzhen Zhang1, Yuhuan Qiao1

  • 1a The First Affiliated Hospital of Zhengzhou University , Zhengzhou , China.

Abstract

Insights

This study reveals microRNA-1297 (miR-1297) is repressed in cervical cancer, promoting tumor growth by activating phosphatase and tensin homolog (PTEN). MiR-1297 may be a therapeutic target for human cervical carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Human cervical carcinoma oncogenic mechanisms are not fully understood.
  • A newly discovered therapeutic microRNA (miRNA) was investigated for its biological role.
  • Understanding miRNA's role is crucial for developing new cervical cancer therapies.

Purpose of the Study:

  • To elucidate the biological role of miR-1297 in human cervical carcinoma.
  • To investigate the relationship between miR-1297 and phosphatase and tensin homolog (PTEN) in cervical cancer.
  • To determine if miR-1297 can be a therapeutic target for cervical cancer.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to profile miR-1297 and PTEN expression.
  • Cell proliferation assays (CCK-8, colony formation) and flow cytometry for apoptosis analysis.
  • Western blotting and 3'UTR assays to validate miR-1297 targeting of PTEN.

Main Results:

  • MiR-1297 was found to be repressed, while PTEN was activated in human cervical cancer tissues.
  • Overexpression of miR-1297 in HeLa cells led to increased proliferation and decreased apoptosis.
  • PTEN silencing mimicked miR-1297 overexpression effects, inhibiting cell growth and apoptosis.

Conclusions:

  • MiR-1297 contributes to human cervical carcinoma development by targeting PTEN.
  • MiR-1297 demonstrates potential as a therapeutic miRNA for cervical cancer.
  • Further research into miR-1297 is warranted for its clinical application.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Binet's Contribution to Measures of Intelligence01:23

Binet's Contribution to Measures of Intelligence

Alfred Binet, along with his student Théophile Simon, was tasked by the French Ministry of Education in 1904 to create a method for identifying students who struggled to learn through conventional classroom instruction. This initiative aimed to address overcrowding by placing such students in specialized schools. Binet and Simon developed an intelligence test comprising 30 tasks, ranging from simple commands, like touching one's nose or ear, to more complex tasks, such as drawing...
1.7K
Wechsler's Contribution to Measures of Intelligence01:23

Wechsler's Contribution to Measures of Intelligence

David Wechsler, a psychologist who worked with World War I veterans, developed a significant IQ test in 1939 called the Wechsler-Bellevue Intelligence Scale. This test was innovative because it combined several subtests that measured both verbal and nonverbal skills, reflecting Wechsler's belief that intelligence is a global capacity involving purposeful action, rational thinking, and effective interaction with the environment. This test later evolved into the Wechsler Adult Intelligence...
2.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K